The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Enbrel in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Enbrel.
Global Revenue Ranking
The action comes after the first drugs subject to pricing negotiations were announced
The IRA programme is facing court challenges from leading drugmakers and industry groups
Competition created by biosimilars has delivered $9.8bn in savings over five years and could reduce patients’ out-of-pocket costs by $238m
Amgen will retain market exclusivity on blockbuster arthritis drug until 2029
Companies will collaborate on novel drugs for autoimmune disorders
The latest Cortellis Drugs to Watch report highlights medicines that treat high prevalence conditions
Scope to build product further with ongoing trials in additional indications
Approval comes over ten months after acquisition announcement
Says affordability is a challenge to access
Higher-than-expected price helps BMS sweeten merger deal
Shares up 6% following court ruling
Contrasts with cholesterol drug Repatha, its price slahed 60% to lift take-up
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology